Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Otto

Showing results (541-550 of 558) with videos related to

Pageof 56
Sort By:
Thyroid : Official Journal of the American Thyroid Association|July 22, 2020
Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and <i>RAS</i> MutationsJuan C Hernandez-Prera, Pablo Valderrabano, Jordan H Creed, et al.
Research Square|July 28, 2023
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
Nature Communications|March 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
JSES International|December 21, 2020
The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part ISarav S Shah, Benjamin T Gaal, Alexander M Roche, et al.
European Urology|July 8, 2020
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate CancerMarkus Kreuz, Dominik J Otto, Susanne Fuessel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trialG Zalcman, A Madroszyk, E Guenzi, et al.
JSES International|February 8, 2021
The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part IISarav S Shah, Alexander M Roche, Spencer W Sullivan, et al.
Environmental Pollution (Barking, Essex : 1987)|August 18, 2018
Understanding context dependency in the response of forest understorey plant communities to nitrogen depositionMichael P Perring, Martin Diekmann, Gabriele Midolo, et al.
Research Square|April 22, 2024
Defining and benchmarking open problems in single-cell analysisMalte D Luecken, Scott Gigante, Daniel B Burkhardt, et al.
Frontiers in Human Neuroscience|May 6, 2021
Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS TechnologiesVinata Vedam-Mai, Karl Deisseroth, James Giordano, et al.
Pageof 56

Showing results (541-550 of 558) with videos related to

Sort By:
Pageof 56
Thyroid : Official Journal of the American Thyroid Association|July 22, 2020
Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and <i>RAS</i> MutationsJuan C Hernandez-Prera, Pablo Valderrabano, Jordan H Creed, et al.
Research Square|July 28, 2023
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
Nature Communications|March 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.
JSES International|December 21, 2020
The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part ISarav S Shah, Benjamin T Gaal, Alexander M Roche, et al.
European Urology|July 8, 2020
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate CancerMarkus Kreuz, Dominik J Otto, Susanne Fuessel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 14, 2026
Four-Year outcomes of first-line Nivolumab plus ipilimumab for 6 months versus continuation in patients with advanced non-small-cell lung cancer Results of the randomized IFCT-1701 "DICIPLE" Phase III trialG Zalcman, A Madroszyk, E Guenzi, et al.
JSES International|February 8, 2021
The modern reverse shoulder arthroplasty and an updated systematic review for each complication: part IISarav S Shah, Alexander M Roche, Spencer W Sullivan, et al.
Environmental Pollution (Barking, Essex : 1987)|August 18, 2018
Understanding context dependency in the response of forest understorey plant communities to nitrogen depositionMichael P Perring, Martin Diekmann, Gabriele Midolo, et al.
Research Square|April 22, 2024
Defining and benchmarking open problems in single-cell analysisMalte D Luecken, Scott Gigante, Daniel B Burkhardt, et al.
Frontiers in Human Neuroscience|May 6, 2021
Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS TechnologiesVinata Vedam-Mai, Karl Deisseroth, James Giordano, et al.
Pageof 56